Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computational approaches that predict metabolic intermediate complex formation with CYP3A4 (+b5).

David R Jones1, Sean Ekins, Lang Li

  • 1Indiana University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Wishard Memorial Hospital, Myers Bldg. W7123, Indianapolis, IN 46220, USA.

Drug Metabolism and Disposition: the Biological Fate of Chemicals
|June 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diaphragm hernia after debulking surgery in patients with ovarian cancer.

Gynecologic oncology reports·2021
Same author

Delivery of oligonucleotide-based therapeutics: challenges and opportunities.

EMBO molecular medicine·2021
Same author

Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Same author

Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids.

STAR protocols·2021
Same author

Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer.

NPJ breast cancer·2021
Same author

Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion: Data From 1,055 Cases of Cancers ≤ 3 cm.

Chest·2021
Same journal

Absorption, metabolism, and excretion of single dose oral [<sup>14</sup>C]camizestrant in healthy human female participants.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Reduction of secondary 3-keto bile acids by aldo-keto reductase 1C1 and 1C4.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Finding the dispersion number (D<sub>N</sub>) of the dispersion model from perfused rat and human liver studies.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.

Drug metabolism and disposition: the biological fate of chemicals·2026
See all related articles

Mechanism-based inhibitors can irreversibly inhibit cytochrome P450 enzymes by forming metabolic intermediate complexes (MICs). This study identified key molecular features, including hydrophobicity and hydrogen bond acceptors, that predict MIC formation with CYP3A4.

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Computational Chemistry

Background:

  • Mechanism-based inhibitors can cause irreversible inhibition of cytochrome P450 enzymes through metabolic intermediate complex (MIC) formation.
  • Understanding the structural determinants of MIC formation is crucial for predicting drug-drug interactions and designing safer pharmaceuticals.

Purpose of the Study:

  • To investigate the propensity of 54 diverse molecules to form MICs with recombinant CYP3A4.
  • To develop predictive models for MIC formation based on molecular structure and physicochemical properties.
  • To identify key structural features associated with CYP3A4 MIC formation.

Main Methods:

  • Spectrophotometric assessment of MIC formation for 54 compounds with recombinant CYP3A4.
  • Physicochemical property comparisons between MIC-forming and non-MIC-forming compounds.

Related Experiment Videos

  • Application of computational pharmacophores, logistic regression, and recursive partitioning (RP) for quantitative structure-activity relationship (QSAR) modeling.
  • Validation of predictive models using an independent test set of 12 literature molecules.

    • Main Results:

    • MIC-forming compounds were significantly larger (mean molecular weight 472 Da) than non-MIC-forming compounds (307 Da).
    • Computational models identified four hydrophobic features and a hydrogen bond acceptor as critical for MIC formation.
    • RP methods and logistic regression models accurately predicted MIC formation status for 10-11 out of 12 independent test molecules.
    • Models highlighted the importance of hydrogen bond acceptors in predicting CYP3A4 MIC formation.

    Conclusions:

    • Molecular structure, particularly the presence of hydrophobic features and hydrogen bond acceptors, can predict CYP3A4 metabolic intermediate complex formation.
    • Developed QSAR models offer a valuable approach for predicting potential CYP3A4 inhibition, aiding in drug development.
    • Further refinement with more data and descriptors can enhance the predictive accuracy of these models.